Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage.

MedStar author(s):
Citation: Atherosclerosis. 269:14-20, 2018 02.PMID: 29253643Institution: MedStar Washington Hospital CenterDepartment: Medicine/Critical Care MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Cerebral Hemorrhage/bl [Blood] | *Cholesterol, LDL/bl [Blood] | *Dyslipidemias/bl [Blood] | *Hematoma/bl [Blood] | Aged | Biomarkers/bl [Blood] | Cerebral Hemorrhage/dg [Diagnostic Imaging] | Cerebral Hemorrhage/mo [Mortality] | Cholesterol, HDL/bl [Blood] | Dyslipidemias/di [Diagnosis] | Dyslipidemias/dt [Drug Therapy] | Dyslipidemias/mo [Mortality] | Female | Hematoma/dg [Diagnostic Imaging] | Hematoma/mo [Mortality] | Hospital Mortality | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors/ad [Administration & Dosage] | Male | Middle Aged | Neuroimaging/mt [Methods] | Patient Admission | Prognosis | Protective Factors | Retrospective Studies | Risk Factors | Time Factors | Tomography, X-Ray ComputedYear: 2018ISSN:
  • 0021-9150
Name of journal: AtherosclerosisAbstract: BACKGROUND AND AIMS: The relationship between lipoprotein levels, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and clinical outcome after intracerebral hemorrhage (ICH) remains controversial. We sought to evaluate the association of lipoprotein cholesterol levels and statin dosage with clinical and neuroimaging outcomes in patients with ICH.CONCLUSIONS: Higher LDL-C levels at hospital admission were an independent predictor for lower likelihood of hematoma expansion and decreased in-hospital mortality in patients with acute spontaneous ICH. This association requires independent confirmation. Copyright (c) 2017 Elsevier B.V. All rights reserved.METHODS: Data on consecutive patients hospitalized with spontaneous acute ICH was prospectively collected over a 5-year period and retrospectively analyzed. Demographic characteristics, clinical severity documented by NIHSS-score and ICH-score, neuroimaging parameters, pre-hospital statin use and doses, and LDL-C and HDL-C levels were recorded. Outcome events characterized were hematoma volume, hematoma expansion, in-hospital functional outcome, and in-hospital mortality.RESULTS: A total of 672 patients with acute ICH [(mean age 61.6 +/- 14.0 years, 43.6% women, median ICH score 1 (IQR: 0-2)] were evaluated. Statin pretreatment was not associated with neuroimaging or clinical outcomes. Higher LDL-C levels were associated with several markers of poor clinical outcome and in-hospital mortality. LDL-C levels were independently and negatively associated with the cubed root of hematoma volume (linear regression coefficient -0.021, 95% CI: -0.042--0.001; p = 0.049) on multiple linear regression models. Higher admission LDL-C (OR 0.88, 95% CI 0.77-0.99; p = 0.048) was also an independent predictor for decreased hematoma expansion. Higher admission LDL-C levels were independently (p < 0.001) associated with lower likelihood of in-hospital mortality (OR per 10 mg/dL increase 0.68, 95% CI: 0.57-0.80) in multivariable logistic regression models.All authors: Alexandrov AV, Alexandrov AW, Burgess LG, Chang JJ, Dillard K, Goyal N, Katsanos AH, Kerro A, Khorchid Y, Tsivgoulis GFiscal year: FY2018Digital Object Identifier: Date added to catalog: 2018-01-18
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 29253643 Available 29253643

BACKGROUND AND AIMS: The relationship between lipoprotein levels, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and clinical outcome after intracerebral hemorrhage (ICH) remains controversial. We sought to evaluate the association of lipoprotein cholesterol levels and statin dosage with clinical and neuroimaging outcomes in patients with ICH.

CONCLUSIONS: Higher LDL-C levels at hospital admission were an independent predictor for lower likelihood of hematoma expansion and decreased in-hospital mortality in patients with acute spontaneous ICH. This association requires independent confirmation. Copyright (c) 2017 Elsevier B.V. All rights reserved.

METHODS: Data on consecutive patients hospitalized with spontaneous acute ICH was prospectively collected over a 5-year period and retrospectively analyzed. Demographic characteristics, clinical severity documented by NIHSS-score and ICH-score, neuroimaging parameters, pre-hospital statin use and doses, and LDL-C and HDL-C levels were recorded. Outcome events characterized were hematoma volume, hematoma expansion, in-hospital functional outcome, and in-hospital mortality.

RESULTS: A total of 672 patients with acute ICH [(mean age 61.6 +/- 14.0 years, 43.6% women, median ICH score 1 (IQR: 0-2)] were evaluated. Statin pretreatment was not associated with neuroimaging or clinical outcomes. Higher LDL-C levels were associated with several markers of poor clinical outcome and in-hospital mortality. LDL-C levels were independently and negatively associated with the cubed root of hematoma volume (linear regression coefficient -0.021, 95% CI: -0.042--0.001; p = 0.049) on multiple linear regression models. Higher admission LDL-C (OR 0.88, 95% CI 0.77-0.99; p = 0.048) was also an independent predictor for decreased hematoma expansion. Higher admission LDL-C levels were independently (p < 0.001) associated with lower likelihood of in-hospital mortality (OR per 10 mg/dL increase 0.68, 95% CI: 0.57-0.80) in multivariable logistic regression models.

English

Powered by Koha